Triana Lina, Aggarwal Nupur, Liscano Esteban
, Cali, Colombia.
, New Delhi, India.
Aesthetic Plast Surg. 2025 Jan 30. doi: 10.1007/s00266-025-04659-5.
The 2021 ISAPS global survey shows a 49.6% rise in demand for breast implant explantation from 2017. The current challenge is to formulate a standardized technique of mastopexy after explantation, which counters the volume deficit and skin redundancy post removal of implant, giving aesthetically pleasing breast. In this paper, we describe the technique of explantation mastopexy based on superiorly based infra-areolar dermoglandular flap and retrospectively analyse the data for past 3 years.
After Institutional review approval, a retrospective analysis of data extracted for breast explantation and mastopexy using the author's technique was done from 1st June 2021 to 31st August 2023. The surgery was performed by the principal author in a single centre. A post-operative Breast-Q questionnaire after 2 weeks for outcome analysis was sent through email.
A total of 150 patients were operated during study time period with mean age of 47.85 ± 9.71years. The reasons for explantation included patient no longer feeling the need for breast implant (66%), breast implant-associated illness (27.33%), implant rupture (4.66%) and capsular contracture (2%). Explanation surgery was seen after mean duration of 14.70 ± 5.68 years after breast augmentation. The post-operative outcome was uneventful for 141 cases (94%). On analysis of questionnaire, 67.8 was mean score for satisfaction with breasts and 56.4 for satisfaction with outcome of surgery for the 100 responses received.
The surgical technique here uses a superiorly based infra-areolar dermoglandular flap which uses own inferior breast tissue to provide upper and medial pole fullness by tacking to pectoral fascia providing a sturdy anchor. The use of inferior breast tissue to augment the central mound shifts up the inframammary crease. The study also objectively evaluates outcome using Breast-Q questionnaire analysis but lacks comparison with other techniques.
Superiorly based infra-areolar dermoglandular flap with folding and tacking to pectoral fascia is a safe technique to manage post breast implant explantation volume deflation.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
2021年国际美容整形外科学会（ISAPS）全球调查显示，自2017年以来，乳房植入物取出术的需求增长了49.6%。当前的挑战是制定一种乳房植入物取出术后的标准化乳房上提技术，以应对植入物取出后的体积不足和皮肤冗余问题，从而塑造出美观的乳房。在本文中，我们描述了基于乳晕上蒂真皮腺体瓣的乳房植入物取出乳房上提技术，并对过去3年的数据进行了回顾性分析。
经机构审查批准后，对2021年6月1日至2023年8月31日期间采用作者技术进行乳房植入物取出和乳房上提的数据进行回顾性分析。手术由第一作者在单一中心进行。术后2周通过电子邮件发送乳房Q问卷进行结果分析。
在研究期间共对150例患者进行了手术，平均年龄为47.85±9.71岁。取出植入物的原因包括患者不再觉得需要乳房植入物（66%）、乳房植入物相关疾病（27.33%）、植入物破裂（4.66%）和包膜挛缩（2%）。隆胸术后平均14.70±5.68年进行了取出手术。141例（94%）患者术后恢复顺利。在对问卷的分析中，收到的100份回复中，对乳房的满意度平均得分为67.8分，对手术结果的满意度平均得分为56.4分。
这里的手术技术使用乳晕上蒂真皮腺体瓣，利用自身乳房下部组织通过固定于胸肌筋膜来提供上半部分和内侧的丰满度，从而提供一个稳固的固定点。利用乳房下部组织增加中央隆起会使乳房下皱襞上移。该研究还通过乳房Q问卷分析客观评估了结果，但缺乏与其他技术的比较。
乳晕上蒂真皮腺体瓣折叠并固定于胸肌筋膜是一种安全的技术，可用于处理乳房植入物取出后的体积缩小问题。
证据水平III：本期刊要求作者为每篇文章指定证据水平。有关这些循证医学评级的完整描述，请参阅目录或在线作者指南www.springer.com/00266。
